Retatrutide weight loss treatment

Retatrutide is an investigational weight loss injection currently being studied in clinical trials. While early research has generated significant interest, it has not been approved or licensed in the UK and is not currently available by prescription.

What is retatrutide?

Retatrutide is an investigational medicine currently being studied in Phase 3 clinical trials. It is a once-weekly injection being developed by Eli Lilly for obesity, weight management, type 2 diabetes, and other obesity-related conditions.

Unlike currently available weight loss injections, retatrutide activates three hormone receptors involved in appetite regulation, blood sugar control, and energy balance: GLP-1, GIP, and glucagon. Because of this, it is often referred to as a "triple agonist".

Retatrutide has not been approved by the MHRA, FDA, or any other regulatory authority worldwide. It remains an investigational medicine and can currently only be accessed through approved clinical trials.

Disclaimer
This information on this page is provided to help explain the latest developments in weight management treatments only. Retatrutide is not licensed for use in the UK and is not available for prescription, supply or purchase. The content on this page does not promote an unlicensed medicine, and any future treatment decisions must be made by a qualified prescriber in line with applicable UK regulations.

0
1
2
3
4
01

How retatrutide works

Retatrutide is designed to activate receptors for three naturally occurring hormones involved in appetite, digestion, blood sugar regulation, and energy use.

GLP-1 helps slow digestion, increase feelings of fullness, and reduce appetite. GIP supports the body's response to food and blood sugar regulation. Glucagon is believed to influence how the body uses and burns stored energy. Together, these pathways are being studied for their potential combined impact on weight management.

Unlike current weight loss medications that target one or two hormonal pathways, retatrutide's triple-action approach is being investigated to understand whether it may provide additional benefits for weight management and metabolic health.

02

What do we know so far?

Retatrutide is currently being evaluated in large international clinical trial programmes studying obesity, overweight, type 2 diabetes, obstructive sleep apnoea, cardiovascular disease, liver disease, and other obesity-related conditions.

Early trial results have generated significant interest within obesity medicine, with researchers continuing to assess its effectiveness, safety profile, and long-term outcomes. However, it is important to remember that clinical trial findings do not guarantee future approval or availability.

Because research is ongoing, information about dosing, eligibility criteria, availability, and future pricing may change as additional evidence becomes available.

03

Can you get retatrutide in the UK?

No. Retatrutide is not currently available in the UK through NHS services, private prescriptions, pharmacies, or online prescribing services.

At present, the only legitimate way to access retatrutide is by participating in an approved clinical trial and meeting that study's eligibility criteria. Patients interested in participating in research can explore opportunities through the UK's National Institute for Health and Care Research (NIHR) Be Part of Research programme: NIHR Be Part of Research.

Future availability will depend on the completion of ongoing clinical trials and subsequent regulatory review by organisations such as the MHRA.

04

Beware of unlicensed retatrutide products

As interest in retatrutide has grown, reports of unlicensed and potentially counterfeit products being sold online and through social media have increased.

Because retatrutide has not been approved anywhere in the world, no pharmacy, clinic, or website can legally supply it as a licensed medicine. Products claiming to contain retatrutide may contain unknown ingredients, contaminants, incorrect doses, or entirely different substances.

If you are considering weight loss treatment, we strongly recommend seeking advice from a regulated healthcare professional and only obtaining medicines through registered UK pharmacies and approved prescribing services.

Your treatment in three easy steps

From a conversation to a precise formulation delivered to your door.

Free online Consultation

A dedicated session with a clinician who reviews your screening, explains your options, and recommends the safest, most effective pathway.

Delivered discreetly

Your prescribed therapy is clinically checked and dispatched directly to you, with clear instructions and ongoing support.

4-week reviews

Monthly reviews, lifestyle guidance, and 24/7 support to ensure your treatment remains safe, effective, and fully supported.

Start your consultation

Arrange a suitable time for an online appointment.

More weight loss options

View our full range of weight loss treatment

FAQs

Find clear answers to common questions about our weight-management service.

Is retatrutide available in the UK?

No. Retatrutide is not licensed or approved in the UK and cannot currently be prescribed by NHS or private healthcare providers. It remains available only through approved clinical trials.

Is retatrutide Safe?

The safety of retatrutide is still being evaluated in ongoing clinical trials. Because it has not yet completed the approval process, long-term safety and effectiveness data are still being collected.

What side effects have been reported in clinical trials?

The most commonly reported side effects have been gastrointestinal and include nausea, vomiting, diarrhoea and constipation. Researchers continue to monitor its safety profile as clinical trials progress.

Can I join a retatrutide clinical trial?

Possibly. Clinical trials have specific eligibility criteria that vary between studies. Patients interested in research opportunities can explore active studies through the NIHR Be Part of Research programme and other approved clinical trial registries.

Can I Buy retatrutide Online?

No legitimate UK pharmacy can sell retatrutide at this time. Any products claiming to contain retatrutide should be treated with caution, as they may be counterfeit, unregulated or potentially dangerous.

Still have questions?

Our team is ready to help you find the answers.

Registered with the General Pharmaceutical Council

GPhC Registration No: 9012289
Registered Owner: Cube Therapies Ltd
Superintendent Pharmacist: Mr Nasir Khan